Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results